SyntheticGestalt
Biotechnology ResearchUnited Kingdom11-50 Employees
We are developing machine learning models for drug discovery and software for facilitating and automating research in the life-sciences industry.
Insights
Innovative R&D Focus SyntheticGestalt specializes in applying AI and machine learning models to accelerate drug discovery and development, indicating a strong demand for advanced AI, cloud computing, and data management solutions tailored to biotech research.
Strategic Partnerships The company's collaborations with industry leaders like Enamine and partnerships with Tokyo Tech demonstrate a focus on co-developing AI-driven chemical and pharmaceutical solutions, offering opportunities for technology providers and joint product integrations.
Recognition and Credibility Winning the Excellent Presentation Award at CBI Society 2023 enhances the company's credibility, making it an attractive prospect for investors and vendors seeking innovative biotech research collaborations.
Funding and Growth Potential With over 11 million USD in funding and a revenue range of 1 to 10 million USD, SyntheticGestalt is positioned for further growth, presenting opportunities for funding agencies and enterprise solution providers targeting expanding biotech startups.
Emerging Market Participant Operating in the dynamic genomic and drug discovery sector with recent presentations at major tech events like NVIDIA GTC 2025, the company is a potential customer for advanced AI platforms, data security solutions, and cloud infrastructure providers aiming to serve innovative biotech firms.
SyntheticGestalt Tech Stack
SyntheticGestalt uses 8 technology products and services including Prismic, Cybot, Cookiebot, and more. Explore SyntheticGestalt's tech stack below.
- PrismicContent Management System
- CybotCookie Compliance
- CookiebotCookie Compliance
- Google CloudInfrastructure As A Service
- ReactJavascript Frameworks
- GitHub PagesPlatform As A Service
- RubyProgramming Languages
- Node.jsProgramming Languages
Media & News
SyntheticGestalt's Email Address Formats
SyntheticGestalt uses at least 1 format(s):
| SyntheticGestalt Email Formats | Percentage |
| F.Last@syntheticgestalt.com | 50% |
| F.Last@syntheticgestalt.com | 50% |
Frequently Asked Questions
Where is SyntheticGestalt's headquarters located?
SyntheticGestalt's main headquarters is located at 20 Great Chapel Street, London, England W1F 8FW, GB. The company has employees across 2 continents, including AsiaEurope. What is SyntheticGestalt's official website and social media links?
SyntheticGestalt's official website is syntheticgestalt.com and has social profiles on LinkedInCrunchbase.What is SyntheticGestalt's SIC code NAICS code?
SyntheticGestalt's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does SyntheticGestalt have currently?
As of October 2025, SyntheticGestalt has approximately 16 employees across 2 continents, including AsiaEurope. Key team members include Cto: K. K.Cfo: M. K.Head Of Ceo Office: K. F.. Explore SyntheticGestalt's employee directory with LeadIQ.What industry does SyntheticGestalt belong to?
SyntheticGestalt operates in the Biotechnology Research industry. What technology does SyntheticGestalt use?
SyntheticGestalt's tech stack includes PrismicCybotCookiebotGoogle CloudReactGitHub PagesRubyNode.js. What is SyntheticGestalt's email format?
SyntheticGestalt's email format typically follows the pattern of F.Last@syntheticgestalt.com. Find more SyntheticGestalt email formats with LeadIQ. How much funding has SyntheticGestalt raised to date?
As of October 2025, SyntheticGestalt has raised $11M in funding. The last funding round occurred on Sep 29, 2021 for $11M.When was SyntheticGestalt founded?
SyntheticGestalt was founded in 2018.
Company Overview
- Headquarters
- 20 Great Chapel Street, London, England W1F 8FW, GB
- Website
- syntheticgestalt.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2018
- Employees
- 11-50
Media & News
Funding & Financials
- $11M
SyntheticGestalt has raised a total of $11M of funding over 3 rounds. Their latest funding round was raised on Sep 29, 2021 in the amount of $11M.
- $1M$10M
SyntheticGestalt's revenue is estimated to be in the range of $1M$10M
Funding & Financials
- $11M
SyntheticGestalt has raised a total of $11M of funding over 3 rounds. Their latest funding round was raised on Sep 29, 2021 in the amount of $11M.
- $1M$10M
SyntheticGestalt's revenue is estimated to be in the range of $1M$10M
Company Leadership
K. K.Cto- M. K.Cfo
- K. F.Head Of Ceo Office
N. F.Head Of Hr & Pr- D. M.Head Of Ai Business
Employee Directory
- N. F.Head Of Hr & Pr
- D. M.Head Of Ai Business
S. S.Senior Manager Of Finance And Accounting- A. S.Project Lead And Senior Manager Of Hr
- M. I.Recruiting Manager
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
